| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Altaf A Kondkar | |
| Khaled K Abu-Amero | |||
| P2860 | cites work | Detection of microRNA expression in human peripheral blood microvesicles | Q21144210 |
| Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association | Q22241929 | ||
| Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology: | Q22242896 | ||
| Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee | Q22306347 | ||
| Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs | Q24302072 | ||
| The Drosha-DGCR8 complex in primary microRNA processing | Q24318603 | ||
| Secretory mechanisms and intercellular transfer of microRNAs in living cells | Q24603413 | ||
| Circulating microRNAs are new and sensitive biomarkers of myocardial infarction | Q24606701 | ||
| miRBase: integrating microRNA annotation and deep-sequencing data | Q24615914 | ||
| Circulating microRNAs as stable blood-based markers for cancer detection | Q24652098 | ||
| Most mammalian mRNAs are conserved targets of microRNAs | Q24655061 | ||
| The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis | Q24656947 | ||
| A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure | Q24673535 | ||
| Circulating microRNAs: biomarkers or mediators of cardiovascular diseases? | Q26992023 | ||
| An extensive class of small RNAs in Caenorhabditis elegans | Q27860626 | ||
| The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 | Q27860849 | ||
| MicroRNAs: small RNAs with a big role in gene regulation | Q27860896 | ||
| Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells | Q27860960 | ||
| Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs | Q27861053 | ||
| MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice | Q28115423 | ||
| MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. | Q37328435 | ||
| Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis | Q37360422 | ||
| Circulating microRNAs levels in Chinese heart failure patients caused by dilated cardiomyopathy | Q37387253 | ||
| microRNA Biogenesis and Function : An overview | Q37900908 | ||
| Biogenesis and regulation of cardiovascular microRNAs. | Q37903568 | ||
| Signature microRNA expression profile of essential hypertension and its novel link to human cytomegalovirus infection | Q38489102 | ||
| Prospective study on circulating MicroRNAs and risk of myocardial infarction | Q39583273 | ||
| microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart | Q40036277 | ||
| Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans | Q41412919 | ||
| Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). | Q41875540 | ||
| Circulating microRNAs (miR-423-5p, miR-208a and miR-1) in acute myocardial infarction and stable coronary heart disease | Q43798118 | ||
| Diagnostic potential of circulating miR-499-5p in elderly patients with acute non ST-elevation myocardial infarction. | Q44134695 | ||
| Usefulness of high-sensitivity troponin T for the evaluation of patients with acute chest pain and no or minimal myocardial damage. | Q46328675 | ||
| Relationship of MRI-determined infarct size and cTnI measurements in patients with ST-elevation myocardial infarction | Q47244382 | ||
| Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases | Q28131780 | ||
| The small RNA profile during Drosophila melanogaster development | Q28201894 | ||
| Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction | Q28264011 | ||
| Inhibition of translational initiation by Let-7 MicroRNA in human cells | Q28265842 | ||
| A translational study of circulating cell-free microRNA-1 in acute myocardial infarction | Q28275588 | ||
| Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2 | Q28295844 | ||
| The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2 | Q28295943 | ||
| MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts | Q28511032 | ||
| Control of stress-dependent cardiac growth and gene expression by a microRNA | Q28587851 | ||
| Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma | Q29547772 | ||
| Export of microRNAs and microRNA-protective protein by mammalian cells | Q29614234 | ||
| MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins | Q29615034 | ||
| Small non-coding RNAs in animal development | Q29616776 | ||
| The MicroRNA Spectrum in 12 Body Fluids | Q29618068 | ||
| Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection | Q29618076 | ||
| Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs | Q29618428 | ||
| MicroRNA expression aberration as potential peripheral blood biomarkers for schizophrenia | Q33955198 | ||
| Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes | Q34127486 | ||
| MicroRNAs in the cardiovascular system | Q34175801 | ||
| Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage | Q34189929 | ||
| Serum microRNAs profile from genome-wide serves as a fingerprint for diagnosis of acute myocardial infarction and angina pectoris | Q34704614 | ||
| Pervasive roles of microRNAs in cardiovascular biology | Q34775686 | ||
| Plasma miR-208 as a biomarker of myocardial injury | Q34998594 | ||
| Signature of circulating microRNAs as potential biomarkers in vulnerable coronary artery disease | Q35067334 | ||
| Profiling of circulating microRNAs: from single biomarkers to re-wired networks | Q35792720 | ||
| A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer | Q36038792 | ||
| Cell-free Circulating miRNA Biomarkers in Cancer | Q36316601 | ||
| Early assessment of acute coronary syndromes in the emergency department: the potential diagnostic value of circulating microRNAs | Q36389315 | ||
| Strategies to determine the biological function of microRNAs | Q36493248 | ||
| Circulating (cell-free) nucleic acids--a promising, non-invasive tool for early detection of several human diseases | Q36731622 | ||
| miRNAs at the heart of the matter | Q36785011 | ||
| Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis | Q36893701 | ||
| Circulating miRNAs: cell-cell communication function? | Q36962750 | ||
| Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study | Q37036751 | ||
| MicroRNAs flex their muscles | Q37104195 | ||
| Requiem for a heavyweight: the demise of creatine kinase-MB. | Q37327923 | ||
| MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction | Q51652483 | ||
| Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. | Q54356342 | ||
| Assessment of plasma miRNAs in congestive heart failure. | Q54397399 | ||
| Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. | Q54408211 | ||
| Circulating microRNAs in patients with coronary artery disease. | Q54421687 | ||
| Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. | Q54439228 | ||
| MiR423-5p as a circulating biomarker for heart failure. | Q54439825 | ||
| MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo. | Q54566995 | ||
| Executive Summary: Heart Disease and Stroke Statistics—2010 Update | Q57413935 | ||
| miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1 | Q83034995 | ||
| Use of circulating microRNAs to diagnose acute myocardial infarction | Q83262798 | ||
| Plasma microRNA 499 as a biomarker of acute myocardial infarction | Q84068842 | ||
| Cardiospecific microRNA plasma levels correlate with troponin and cardiac function in patients with ST elevation myocardial infarction, are selectively dependent on renal elimination, and can be detected in urine samples | Q84435715 | ||
| Secreted monocytic miR-150 enhances targeted endothelial cell migration | Q84525686 | ||
| Circulating miR-133a and miR-423-5p fail as biomarkers for left ventricular remodeling after myocardial infarction | Q85950682 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microRNA | Q310899 |
| cardiovascular disease | Q389735 | ||
| biomarker | Q864574 | ||
| P304 | page(s) | 821823 | |
| P577 | publication date | 2015-02-01 | |
| P1433 | published in | BioMed Research International | Q17509958 |
| P1476 | title | Utility of circulating microRNAs as clinical biomarkers for cardiovascular diseases | |
| P478 | volume | 2015 |
| Q26778588 | Beyond the Limits: Clinical Utility of Novel Cardiac Biomarkers |
| Q55610979 | Biomarkers, myocardial fibrosis and co-morbidities in heart failure with preserved ejection fraction: an overview. |
| Q64062611 | Circular RNAs as potential biomarkers and therapeutics for cardiovascular disease |
| Q92852699 | Circulating adiposity-related microRNAs as predictors of the response to a low-fat diet in subjects with obesity |
| Q38878172 | Circulating long noncoding RNAs as novel biomarkers of human diseases |
| Q89444419 | Circulating microRNA expression profiling and bioinformatics analysis of dysregulated microRNAs of patients with coronary artery disease |
| Q26744645 | Circulating microRNAs as potential biomarkers for diagnosis of congenital heart defects |
| Q94469625 | Comprehensive analysis of cardiac function, blood biomarkers and histopathology for milrinone-induced cardiotoxicity in cynomolgus monkeys |
| Q33816471 | Creating a Biomarker Panel for Early Detection of Chemotherapy Related Cardiac Dysfunction in Breast Cancer Patients |
| Q41807019 | Inflammation Related MicroRNAs Are Modulated in Total Plasma and in Extracellular Vesicles from Rats with Chronic Ingestion of Sucrose |
| Q92544047 | MicroRNA-451b Participates in Coronary Heart Disease By Targeting VEGFA |
| Q26801108 | MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer |
| Q58790122 | New Insights in Cardiac β-Adrenergic Signaling During Heart Failure and Aging |
| Q59336594 | RATEmiRs: the rat atlas of tissue-specific and enriched miRNAs database |
| Q89492104 | RATEmiRs: the rat atlas of tissue-specific and enriched miRNAs for discerning baseline expression exclusivity of candidate biomarkers |
| Q60304369 | Screening for Circulating MiR-208a and -b in Different Cardiac Arrhythmias of Dogs |
| Q55549139 | Stability of Circulating Exosomal miRNAs in Healthy Subjects. |
| Q64248970 | The MicroRNA Family Both in Normal Development and in Different Diseases: The miR-17-92 Cluster |
| Q52608599 | The Potential Role of Platelet-Related microRNAs in the Development of Cardiovascular Events in High-Risk Populations, Including Diabetic Patients: A Review. |
| Q50420098 | The peptide lycosin-I attenuates TNF-α-induced inflammation in human umbilical vein endothelial cells via IκB/NF-κB signaling pathway. |
| Q99237852 | Use of an Exposome Approach to Understand the Effects of Exposures From the Natural, Built, and Social Environments on Cardio-Vascular Disease Onset, Progression, and Outcomes |
| Q92782452 | miR-130a and Tgfβ Content in Extracellular Vesicles Derived from the Serum of Subjects at High Cardiovascular Risk Predicts their In-Vivo Angiogenic Potential |
| Q89019543 | miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges |
| Q92923058 | miRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis |
Search more.